Effective date
Medicare changes effective March 18, 2022
1 CMS and MAC policy update takes effect on this date. Every entry links to the government document it came from.
Fewer than 5 updates — this date is not listed in the index.
FDA · 1
- FDA Approval: OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) — Type 1 - New Molecular Entity
FDA-BLA761234NationalOncologysource ↗